QAM
BMRN icon

QCI Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

QCI Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-80
Closed -$7K – 649
2017
Q1 		$7K Buy
+80
New +$7.12K ﹤0.01% 425
2016
Q4 		– Sell
-500
Closed -$46K – 527
2016
Q3 		$46K Hold
500
– – 0.01% 208
2016
Q2 		$39K Hold
500
– – 0.01% 232
2016
Q1 		$41K Hold
500
– – 0.01% 222
2015
Q4 		$52K Hold
500
– – 0.01% 190
2015
Q3 		$53K Hold
500
– – 0.01% 194
2015
Q2 		$68K Hold
500
– – 0.01% 164
2015
Q1 		$62K Buy
+500
New +$53K 0.01% 168

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return